Literature DB >> 7589349

Hypercalcaemia caused by all-trans retinoic acid (ATRA) treatment in a case of acute promyelocytic leukaemia was manageable after decreasing the ATRA dose to 27 mg/m2/day.

P Lemez.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7589349

Source DB:  PubMed          Journal:  Eur J Haematol        ISSN： 0902-4441            Impact factor:   2.997


× No keyword cloud information.
  4 in total

1.  All-Trans-Retinoic-Acid Unmasking Hypercalcemia of Hyperparathyroidism.

Authors:  Uday Yanamandra; Kamal Kant Sahu; Alka Khadwal; Gaurav Prakash; Subhash Chander Varma; Pankaj Malhotra
Journal:  Indian J Hematol Blood Transfus       Date:  2015-09-08       Impact factor: 0.900

2.  A phase II trial of a differentiating agent (tRA) with cisplatin-VP 16 chemotherapy in advanced non-small cell lung cancer.

Authors:  R Thiruvengadam; J O Atiba; S H Azawi
Journal:  Invest New Drugs       Date:  1996       Impact factor: 3.850

3.  Differential enhancement of leukaemia cell differentiation without elevation of intracellular calcium by plant-derived sesquiterpene lactone compounds.

Authors:  S H Kim; M Danilenko; T S Kim
Journal:  Br J Pharmacol       Date:  2008-08-25       Impact factor: 8.739

Review 4.  The safety of isotretinoin treatment in patients with bone fractures.

Authors:  Bartosz Miziołek; Beata Bergler-Czop; Anna Stańkowska; Ligia Brzezińska-Wcisło
Journal:  Postepy Dermatol Alergol       Date:  2019-02-22       Impact factor: 1.837
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.